Literature DB >> 24676301

Hypoxia among patients on the liver-transplant waiting list.

Lucas Souto Nacif1, Wellington Andraus1, Kathryn Sartori1, Carlos Marlon Benites1, Vinicius Rocha Santos1, Joel Avancini Rocha-Filho1, Luiz Carneiro D'Albuquerque1.   

Abstract

BACKGROUND: Hepatopulmonary syndrome is formed by a triad of liver disease, intrapulmonary vascular dilatation and changes in blood gases. This condition is present in 4-32% of patients with cirrhosis. AIM: To analyze the blood gas changes data of patients in liver-transplant waiting list.
METHOD: Clinical data of 279 patients in liver transplantation waiting list in May 2013 were studied. Overall patient was analyzed by the demographic aspects, laboratorial and image findings on exams that determine lung disease (hypoxemia) in these cirrhotic patients. The mean values and standard deviations were used to examine normally distributed variables.
RESULTS: There was a high prevalence of male patients (68%); the mean age was 51(± 5,89) years, and the predominant reason for listing was hepatitis C cirrhosis. The MELD score mean was 16 ± 5,89, without prioritization or special situation. The most common blood type was O in 129 cases (46%) and the mean of body max index was 25,94 ± 4,58. Regarding arterial blood gas tests was observed 214 patients with PaO2 <90 mmHg, 80 with PaO2 <80 mmHg and 39 with PaO2 <50 mmHg. In relation to O2 saturation, 50 patients had <90%, 33 <80% and 10 <50%.
CONCLUSION: Was observed a high rate of hypoxemia in patients on waiting list liver transplant. Due to the high severity and morbidity, is suggested better monitoring and therapeutic support to hypoxemic patients on liver transplant waiting list.

Entities:  

Mesh:

Year:  2014        PMID: 24676301      PMCID: PMC4675473          DOI: 10.1590/s0102-67202014000100014

Source DB:  PubMed          Journal:  Arq Bras Cir Dig        ISSN: 0102-6720


  11 in total

Review 1.  Pulmonary-Hepatic vascular Disorders (PHD).

Authors:  R Rodríguez-Roisin; M J Krowka; Ph Hervé; M B Fallon
Journal:  Eur Respir J       Date:  2004-11       Impact factor: 16.671

2.  Liver transplantation for hepatopulmonary syndrome (HPS): what is the MESSAGE?

Authors:  M J Krowka; M B Fallon
Journal:  Am J Transplant       Date:  2008-03-04       Impact factor: 8.086

Review 3.  Hepatopulmonary syndrome--a liver-induced lung vascular disorder.

Authors:  Roberto Rodríguez-Roisin; Michael J Krowka
Journal:  N Engl J Med       Date:  2008-05-29       Impact factor: 91.245

Review 4.  Hepatopulmonary syndrome.

Authors:  Victor I Machicao; Michael B Fallon
Journal:  Semin Respir Crit Care Med       Date:  2012-03-23       Impact factor: 3.119

5.  Cholangiocyte endothelin 1 and transforming growth factor beta1 production in rat experimental hepatopulmonary syndrome.

Authors:  Bao Luo; Liping Tang; Zhishan Wang; Junlan Zhang; Yiqun Ling; Wenguang Feng; Ju-Zhong Sun; Cecil R Stockard; Andra R Frost; Yiu-Fai Chen; William E Grizzle; Michael B Fallon
Journal:  Gastroenterology       Date:  2005-08       Impact factor: 22.682

Review 6.  Hepatopulmonary syndrome: update on pathogenesis and clinical features.

Authors:  Junlan Zhang; Michael B Fallon
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-07-03       Impact factor: 46.802

Review 7.  Mechanisms of pulmonary vascular complications of liver disease: hepatopulmonary syndrome.

Authors:  Michael B Fallon
Journal:  J Clin Gastroenterol       Date:  2005-04       Impact factor: 3.062

8.  The lung in liver disease: old problem, new concepts.

Authors:  Michael B Fallon; Junlan Zhang
Journal:  Trans Am Clin Climatol Assoc       Date:  2013

9.  Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates.

Authors:  Michael B Fallon; Michael J Krowka; Robert S Brown; James F Trotter; Steven Zacks; Kari E Roberts; Vijay H Shah; Neil Kaplowitz; Lisa Forman; Keith Wille; Steven M Kawut
Journal:  Gastroenterology       Date:  2008-06-20       Impact factor: 22.682

Review 10.  Improvement of hepatopulmonary syndrome after transjugular intrahepatic portasystemic shunting: case report and review of literature.

Authors:  Anil S Paramesh; Sohail Z Husain; Benjamin Shneider; Jeffrey Guller; Ikbal Tokat; Gabriel E Gondolesi; Susan Moyer; Sukru Emre
Journal:  Pediatr Transplant       Date:  2003-04
View more
  2 in total

1.  COMPARATIVE STUDY ON LIVER TRANSPLANTATION WITH AND WITHOUT HEPATOCELLULAR CARCINOMA WITH CIRRHOSIS: ANALYSIS OF MELD, WAITING TIME AND SURVIVAL.

Authors:  Alexandre Coutinho Teixeira de Freitas; Rafael Shinmi Shiguihara; Ruan Teles Monteiro; Thiago Linck Pazeto; Júlio Cezar Uili Coelho
Journal:  Arq Bras Cir Dig       Date:  2016-03

Review 2.  The hepatopulmonary syndrome.

Authors:  Lucas Souto Nacif; Wellington Andraus; Rafael Soares Pinheiro; Liliana Ducatti; Luciana B P Haddad; Luiz Carneiro D'Albuquerque
Journal:  Arq Bras Cir Dig       Date:  2014 Apr-Jun
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.